Position in AMGN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$722,067
+$13,442 QoQ
Shares Held
1,994
-1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,936
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Investment Counsel, Inc holds $4,343,317 across 8 Drug Manufacturers - General names. AMGN ranks #3 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
984 | $1,180,239 | |
| 2 | JNJ |
Johnson & Johnson
|
3,798 | $964,578 | |
| 3 | AMGN |
Amgen Inc
This page
|
1,994 | $722,067 | |
| 4 | ABBV |
AbbVie Inc.
|
1,610 | $405,140 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
5,713 | $329,183 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,050 | $258,997 | |
| 7 | PFE |
Pfizer Inc
|
10,372 | $249,757 | |
| 8 | MRK |
Merck & Co., Inc.
|
1,816 | $233,356 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $722,067 | 1,994 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $708,625 | 2,014 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $659,202 | 2,014 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $579,074 | 2,052 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $684,622 | 2,452 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $732,765 | 2,352 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $614,328 | 2,357 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $770,081 | 2,390 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $1,457,579 | 4,665 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,354,784 | 4,765 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,372,415 | 4,765 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,283,329 | 4,775 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $1,057,703 | 4,764 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $1,149,521 | 4,755 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $1,327,645 | 5,055 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $1,122,492 | 4,980 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $1,252,995 | 5,150 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $1,252,627 | 5,180 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $1,131,599 | 5,030 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $510,360 | 2,400 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $487,500 | 2,000 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $373,215 | 1,500 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $275,904 | 1,200 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $304,992 | 1,200 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $290,107 | 1,230 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $249,357 | 1,230 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||